The main aim of this study was to evaluate the association of plasma GFAP, NfL, and p-tau181 levels with cognitive function and the clinical performance of these markers in the early diagnosis of AD in a real clinical cross-sectional cohort population from the Futian district, Shenzhen city in China. Here, GFAP is linked to Alzheimer disease.